TABLE 2.
Clinical characteristics of patients who underwent genome biopsy with TBB
| Final TBB patients (n = 99) | |
|---|---|
| Age‐median, (range) | |
| Median | 67 (32–90) |
| Sex, n (%) | |
| Male | 58 (58.6) |
| Female | 41 (41.4) |
| Histology, n (%) | |
| Ad including | |
| Ad + SCLC | 75 (75.8) |
| Ad + Sq | |
| Sq | 16 (16.1) |
| NSCLC | 8 (8.1) |
| Stage, n (%) | |
| IIIA,B | 20 (20.2) |
| IVA | 32 (32.3) |
| IVB | 47 (47.5) |
| Tumor location 1 | |
| Central | 34 (34.3) |
| Peripheral | 65 (65.7) |
| Tumor location 2 | |
| Right | |
| Upper and Middle | 29 (29.3) |
| Lower | 24 (24.2) |
| Left | |
| Upper | 24 (24.2) |
| Lower | 22 (22.3) |
| Re‐biopsy for genome analysis | 0 (0) |
| Maximum diameter of tumor (mm) | |
| Median (range) | 40.3 (14.7–102.3) |
| Tumor nuclei content (%) | |
| Median (range) | 50 (10–90) |
| Necrosis tissue content (%) | |
| Median (range) | 10 (0–90) |
| Unconfirmed specimens | 16 (16.2) |